Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Lactobacillus acidophilus L-92 and Improved Immune Modulation

Research synthesisLow evidenceModerate effect5 studies · 5 beneficial · 0 neutral · 0 harmful

Across 5 studies, all reported beneficial effects of Lactobacillus acidophilus L-92 on immune modulation, with a predominant moderate effect size. The evidence includes a statistically significant finding of enhanced phagocytic activity and IFN-γ production in human immune cells, as well as anti-allergic effects via increased IL-12, IFN-γ, and IL-10 and decreased IL-4 from splenocytes. Most studies were reviews focusing on animal populations or general probiotic mechanisms, and doses and study durations were not reported.

Caveats: Available evidence is overwhelmingly positive — clinical literature in this area is subject to publication bias (null-result studies are less likely to be published or indexed). Evidence base is small (only 5 studies) — conclusions should be considered preliminary. Many of the included studies did not reach statistical significance — effect may be smaller than the predominant direction suggests. Most studies are reviews with limited primary data; only one study reported a statistically significant finding.

Generated Jul 11, 2026
5 of 5 papers
Back to top